欧盟EMA药品数据库-欧盟集中审批药品
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Rezdiffra Human resmetirom resmetirom EMEA/H/C/006220 Madrigal Pharmaceuticals EU Limited 2025/08/18 Authorised
Mynzepli Human aflibercept aflibercept EMEA/H/C/006438 Advanz Pharma Limited 2025/08/18 Authorised
Vivlipeg Human pegfilgrastim pegfilgrastim EMEA/H/C/006739 Biosimilar Collaborations Ireland Limited 2025/08/18 Authorised
Eiyzey Human aflibercept aflibercept EMEA/H/C/006745 Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A. 2025/08/14 Authorised
Usymro Human ustekinumab ustekinumab EMEA/H/C/006467 Gedeon Richter Plc. 2025/08/14 Authorised
Vgenfli Human aflibercept aflibercept EMEA/H/C/006192 Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A. 2025/08/14 Authorised
Ogsiveo Human nirogacestat nirogacestat hydrobromide EMEA/H/C/006071 SpringWorks Therapeutics Ireland Limited 2025/08/14 Authorised
Maapliv Human amino acids glycine,L-alanine,L-arginine,L-aspartic acid,L-cysteine hydrochloride monohydrate,L-histidine,L-methionine,L-phenylalanine,L-proline,L-serine,L-threonine,L-tryptophan,L-tyrosine,L-glutamic acid,L-lysine monohydrate,taurine EMEA/H/C/005557 Recordati Rare Diseases 2025/07/28 Authorised
Riulvy Human tegomil fumarate tegomil fumarate EMEA/H/C/006427 Neuraxpharm Pharmaceuticals S.L. 2025/07/28 Authorised
Blenrep Human belantamab mafodotin belantamab mafodotin EMEA/H/C/006511 GlaxoSmithKline Trading Services Limited 2025/07/23 Authorised
Conexxence Human denosumab denosumab EMEA/H/C/006268 Fresenius Kabi Deutschland GmbH 2025/07/18 Authorised
Itovebi Human inavolisib inavolisib EMEA/H/C/006353 Roche Registration GmbH  2025/07/18 Authorised
Emtricitabine / Tenofovir alafenamide Viatris Human emtricitabine;tenofovir alafenamide emtricitabine;tenofovir alafenamide fumarate EMEA/H/C/006469 Viatris Limited 2025/07/18 Authorised
Rolcya Human denosumab denosumab EMEA/H/C/006507 Sandoz GmbH 2025/07/17 Authorised
Bomyntra Human denosumab denosumab EMEA/H/C/006269 Fresenius Kabi Deutschland GmbH 2025/07/17 Authorised
Attrogy Human diflunisal diflunisal EMEA/H/C/006248 Purpose Pharma International AB 2025/07/17 Authorised
Ezmekly Human mirdametinib mirdametinib EMEA/H/C/006460 SpringWorks Therapeutics Ireland Limited 2025/07/17 Authorised
Aucatzyl Human obecabtagene autoleucel obecabtagene autoleucel EMEA/H/C/005907 Autolus GmbH 2025/07/17 Authorised
Oczyesa Human octreotide octreotide hydrochloride EMEA/H/C/006322 Camurus AB 2025/06/30 Authorised
Alyftrek Human deutivacaftor / tezacaftor / vanzacaftor deutivacaftor;tezacaftor;vanzacaftor calcium dihydrate EMEA/H/C/006382 Vertex Pharmaceuticals (Ireland) Limited 2025/06/30 Authorised

数据库说明:

©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase